terazosin

DRUG INTERACTION

Contraindicated  

Serious Use Alternative  

Monitor Closely  

Minor  

Adverse drug reactions:   

Frequency defined  

>10%  

Dizziness  

Asthenia   

1-10%  

Sinusitis  

Dyspnea   

Fatigue  

Headache  

Hypotension   

Palpitation   

Nausea   

Tachycardia  

Amblyopia  

Blurred vision  

Edema  

Back pain   

Flulike syndrome   

Pregnancy warnings:     

US FDA pregnancy category: C 

Breastfeeding warnings:  

The release of the drug into the human breastmilk is unknown 

Pregnancy Categories:      

Category A: Satisfactory and well-controlled studies show no risk to the fetus in the first or later trimester.      

Category B: No evidence shown of risk to the fetus found in animal reproduction studies, and there are not enough studies on pregnant women      

Category C: Adverse effects on the fetus found with evidence in animal reproduction studies and no adequate evidence for a result in humans must take care of potential risks in pregnant women      

Category D: There is adequate data available with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits      

Category X: Drugs listed in this category outweigh risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.      

Category N: There is no data available for the drug under this category

Patient Information Leaflet 

Generic Name: terazosin  

Pronounced: ter-AY-zoe-sin 

Why do we use terazosin?  

terazosin is an anti-hypertensive drug belonging to the subclass alpha-blocker used to treat hypertension. It mainly helps in decrease of high blood pressure and prevent risk of heart stroke, heart attacks and renal problems.